Inventor · disambiguated record
Joachim Broeker
Also filed as: BROEKER JOACHIM
9 granted patents·9 pending applications·20 citations·filing 2015–2024
82Inventor score
Top patents by PatentIndex Score
18 records- 0189US12312363B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Granted May 27, 2025·0 cites·4 claims
- 0289US10144739B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Dec 4, 2018·9 cites·65 claims
- 0388US10246467B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 2, 2019·9 cites·17 claims
- 0479US10919913B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Feb 16, 2021·2 cites·18 claims
- 0578USRE50594ESpiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Granted Sep 23, 2025·0 cites·15 claims
- 0667US2021101912A1New spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 0764US10882866B1Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jan 5, 2021·0 cites·2 claims
- 0862US12060367B2Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2023·Granted Aug 13, 2024·0 cites·49 claims
- 0962US2025002504A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1061US2025019385A1Spirocyclic annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1158US11945812B2Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2021·Granted Apr 2, 2024·0 cites·39 claims
- 1258US10717742B2Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Jul 21, 2020·0 cites·1 claims
- 1356US2023227470A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1455US2025313553A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 1554US2025296940A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 1654US2025129095A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 1753US2025129096A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 1852US2025145608A1Kras degrading compounds comprising annulated 2-amino-3-cyano thiophenesBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joachim Broeker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →